Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNJ | LLY | NVO | ABBV | MRK |
| Company | Johnson & Johnson | Eli Lilly and Company | Novo Nordisk A/S ADR | Abbvie Inc | Merck & Company |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 155.90 | 757.05 | 103.91 | 174.34 | 100.33 |
| High | 157.09 | 761.28 | 104.37 | 176.83 | 101.52 |
| Low | 155.69 | 750.77 | 103.86 | 173.50 | 100.17 |
| Last | 156.94 | 752.40 | 104.65 | 177.28 | 101.58 |
| Change | +1.44 | +2.48 | +2.02 | +5.55 | +1.72 |
| % Change | +0.93% | +0.33% | +1.97% | +3.23% | +1.72% |
| Volume | 901,675 | 638,025 | 540,936 | 1,363,067 | 1,454,324 |
| 20-Day Average Volume | 7,118,057 | 5,446,212 | 6,527,360 | 7,381,322 | 10,663,291 |
| Previous Close | 155.50 | 749.92 | 102.63 | 171.73 | 99.86 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 156.44 | 801.31 | 107.31 | 184.47 | 100.47 |
| 20-Day Raw Stochastic | 51.18% | 23.79% | 33.88% | 26.03% | 62.84% |
| 20-Day Relative Strength | 46.39% | 35.82% | 38.26% | 40.51% | 42.34% |
| Weighted Alpha | +1.85 | +12.35 | -12.06 | +15.53 | -10.95 |
| Today's Opinion | 24% Buy | 56% Sell | 100% Sell | 24% Sell | 88% Sell |
| Previous Opinion | 24% Sell | 56% Sell | 100% Sell | 24% Sell | 100% Sell |
| Last Month's Opinion | 88% Buy | 24% Buy | 88% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.69% since 11/15/24 | +1.60% since 11/15/24 | +2.50% since 11/15/24 | +6.15% since 11/15/24 | +5.04% since 11/15/24 |
| Low | 151.81 on 11/20/24 | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 163.81 on 11/19/24 | 95.26 on 11/19/24 |
| High | 156.65 on 11/22/24 | 761.28 on 11/22/24 | 105.74 on 11/20/24 | 175.16 on 11/22/24 | 101.18 on 11/22/24 |
| 1-Month | |||||
| %Chg | -4.19% since 10/22/24 | -16.61% since 10/22/24 | -10.47% since 10/22/24 | -7.22% since 10/22/24 | -5.14% since 10/22/24 |
| Low | 150.76 on 11/14/24 | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 163.81 on 11/19/24 | 94.48 on 11/15/24 |
| High | 166.00 on 10/23/24 | 907.98 on 10/29/24 | 116.43 on 10/23/24 | 207.32 on 10/31/24 | 107.36 on 10/23/24 |
| 3-Month | |||||
| %Chg | -3.54% since 08/22/24 | -20.54% since 08/22/24 | -23.82% since 08/22/24 | -10.81% since 08/22/24 | -13.20% since 08/22/24 |
| Low | 150.76 on 11/14/24 | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 163.81 on 11/19/24 | 94.48 on 11/15/24 |
| High | 168.85 on 09/04/24 | 972.48 on 08/27/24 | 139.74 on 08/30/24 | 207.32 on 10/31/24 | 120.30 on 09/06/24 |
| 6-Month | |||||
| %Chg | +2.02% since 05/22/24 | -5.57% since 05/22/24 | -22.20% since 05/22/24 | +9.73% since 05/22/24 | -22.84% since 05/22/24 |
| Low | 143.71 on 05/29/24 | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 153.58 on 05/30/24 | 94.48 on 11/15/24 |
| High | 168.85 on 09/04/24 | 972.53 on 08/22/24 | 148.15 on 06/25/24 | 207.32 on 10/31/24 | 134.63 on 06/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 374,385,408 | 711,911,040 | 460,555,456 | 303,470,944 | 252,609,360 |
| Shares Outstanding, K | 2,407,623 | 949,316 | 4,487,532 | 1,767,140 | 2,529,635 |
| Annual Sales | 85,159,000,000 | 34,124,100,000 | 33,724,300,000 | 54,318,000,000 | 60,115,000,000 |
| Annual Net Income | 35,153,000,000 | 5,240,400,000 | 12,150,770,000 | 4,863,000,000 | 365,000,000 |
| Last Quarter Sales | 22,471,000,000 | 11,439,100,000 | 10,511,240,000 | 14,460,000,000 | 16,657,000,000 |
| Last Quarter Net Income | 2,694,000,000 | 970,300,000 | 4,024,170,000 | 1,561,000,000 | 3,157,000,000 |
| 60-Month Beta | 0.53 | 0.43 | 0.42 | 0.63 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.42 on 10/15/24 | 1.18 on 10/30/24 | 0.90 on 11/06/24 | 3.00 on 10/30/24 | 1.57 on 10/31/24 |
| Latest Earnings Date | 10/15/24 | 10/30/24 | 11/06/24 | 10/30/24 | 10/31/24 |
| Most Recent Dividend | 1.240 on 08/27/24 | 1.300 on 11/15/24 | 0.362 on 08/16/24 | 1.550 on 10/15/24 | 0.770 on 09/16/24 |
| Next Ex-Dividends Date | 11/26/24 | 11/15/24 | 08/16/24 | 01/15/25 | 12/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 14.95 | 74.08 | 34.07 | 15.61 | 16.38 |